ibs.GRANADA scientists demonstrate the important role of endocrine therapy in the treatment of breast cancer

by Instituto de Investigación Biosanitaria - Ibs Granada

6 months ago
Abemaciclib, therapy endocrine, breast cancer, positive estrogen receptors and Her-2 negative, MonarchE

It has been shown that the therapy endocrine, combined with a drug used in breast cancer called Abemaciclib, means a treatment with greater safety and better results perceived by patients in the treat...

A pre-disease anti-diabetic and anti-inflammatory diet may contribute to a better prognosis in breast cancer survivors

by ICO - Institut Català d'Oncologia

7 months ago
anti-diabetic and anti-inflammatory diet, breast cancer

A study led by researchers from the Nutrition and Cancer Unit of the Catalan Institute of Oncology and the Biomedical Research Institute of Bellvitge (IDIBELL), published in the scientific journal ...

Artificial intelligence in breast cancer treatment

by Universitat de Barcelona

1 year ago
RadioVal, breast cancer, Artificial intelligence

The University of Barcelona is leading a European project to clinically validate an Artificial Intelligence solution to predict the specific response of each patient in breast cancer chemotherapy.

A new treatment is effective for advanced HER2-low breast cancer

by Fundació Clínic per a la Recerca Biomèdica

1 year ago
HER2, breast cancer, trastuzumab deruxtecan

Researchers from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO)-IDIBELL and the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, par...

A selection of VHIO research highlights at the San Antonio Breast Cancer Symposium 2021

by VHIO

2 years ago
Cancer, VHIO, Breast Cancer, Research

Among the many studies that counted on the participation of VHIO researchers and clinical investigators at VHIO as first and/or co-authors were several clinical trials developed by the SOLTI academic ...

Breast cancer cells create collagen shields to protect themselves from the immune system

by Hospital Universitari de Bellvitge

2 years ago
immune cells, Breast cancer, mammary tumor

The high number of immune cells within tumors is an indicator of a good prognosis, since they attack the tumor and help destroy it.

Seeking out predictive biomarkers to FGFR inhibitors in molecularly-selected metastatic breast cancer

by Vall d’Hebron

2 years ago
breast cancer, FGFR inhibitors

Recently published in Clinical Cancer Research*, results from patient-derived xenografts (PDXs) and breast cancer patient samples support the prospective validation of this approach in luminal CDK...

Gene variants associated to breast cancer

by Abyntek

2 years ago
breast cancer, genetic

Breast cancer risk is determined by several factors and our genetic constellation can play a big part on it.

IRB Barcelona spin-off Inbiomotion’s MAF Test® selects breast cancer patients

by IRB Barcelona - Instituto de Investigación Biomédica

2 years ago
MAF Test®, breast cancer, adjuvant clodronate

IRB Barcelona spin-off Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival

VHIO ‘on the ground’ at ESMO 2021: reporting advances in breast cancer treatment

by VHIO

2 years ago
ESMO, breast cancer, investigators, metastatic

During this week’s virtual 2021 Annual Congress of the European Society for Medical Oncology (ESMO), 16-21 September, studies (co) led by VHIO investigators revealed significant advances in the trea...

New strategies to fight aggressive breast cancer

by Vall d’Hebron

2 years ago
breast cancer, nanoparticles, tumour stem cells

CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles.

Diets that promote inflammation can increase the risk of breast cancer by up to 12%

by Hospital Universitari de Bellvitge

2 years ago
breast cancer, diets, Epidemiology, inflammation

Research carried out by IDIBELL and ICO within the framework of the European EPIC study, which includes the monitoring of more than 300,000 women for 15 years, has determined the inflammatory potentia...